Measuring diagnostic performance of COVID-19 tests: lessons for the next pandemic
- PMID: 34763755
- PMCID: PMC8646981
- DOI: 10.2807/1560-7917.ES.2021.26.45.2101050
Measuring diagnostic performance of COVID-19 tests: lessons for the next pandemic
Comment on
-
Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.Euro Surveill. 2021 Nov;26(44):2100441. doi: 10.2807/1560-7917.ES.2021.26.44.2100441. Euro Surveill. 2021. PMID: 34738515 Free PMC article.
-
Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021.Euro Surveill. 2021 Nov;26(44):2100442. doi: 10.2807/1560-7917.ES.2021.26.44.2100442. Euro Surveill. 2021. PMID: 34738516 Free PMC article.
-
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid and antibody tests up to 22 August 2020.Euro Surveill. 2021 Nov;26(45):2001675. doi: 10.2807/1560-7917.ES.2021.26.45.2001675. Euro Surveill. 2021. PMID: 34763752 Free PMC article.
References
-
- Puyskens A, Krause E, Michel J, Nübling CM, Scheiblauer H, Bourquain D, et al. Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021;26(44):2100442. 10.2807/1560-7917.ES.2021.26.44.2100442 - DOI - PMC - PubMed
-
- Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021;26(44):2100441. 10.2807/1560-7917.ES.2021.26.44.2100441 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical